How the Experts Treat Neuroendocrine Tumors
02/27/2017 - 02/27/2018
This educational program is directed toward gastroenterologists, internists, surgeons, medical oncologists, radiation oncologists, surgical oncologists and other allied healthcare professionals interested in the treatment of patients with neuroendocrine tumors.
Neuroendocrine tumors, while uncommon, are increasing in frequency. Because of the many cell types from which they derive, these tumors present in diverse manifestations, from symptoms consistent with high-grade malignancy to very indolent tumors that manifest as endocrine disturbances due to the secretion of multiple hormones. It is common for the diagnosis to be delayed for years and the classic symptoms to be attributed to more common diagnoses. This results in progression of early stage disease to late stage incurable disease. Psychiatric manifestations may also be present. In the past decade, much has been learned about the treatment of these neoplasms. Increased knowledge of the contribution of surgery to palliation and longevity is now understood. New systemic agents have been developed with indications for long-term control of these cancers. It is important for healthcare practitioners caring for these patients to have an increased understanding of their presentation and treatment.
Upon completion of this activity, participants will be able to:
- Review the newer indications and results of surgical approaches to neuroendocrine neoplasms
- Review indications for systemic therapy of these tumors